If You Think Ebola Was Bad…

Despite the fact that only a handful of people have been infected with Ebola in the United States, widespread public anxiety and media coverage have quickly escalated the virus to the forefront of public health fears. While these concerns are justified, another imminent threat with little to no public awareness is rapidly spreading – antibiotic resistance. […]

Read More…

December 2014: Recent Papers Using Luminex xMAP Technology

As 2014 comes to a close, we have one last highlight of the numerous publications from our customers. We’ve selected seven new papers, featuring customer-developed assays and partner kits, which we thought would be especially interesting to you. Our bibliography helps you stay current with the success that your scientific peers are having while using […]

Read More…

Flu Vaccine Mismatch

This year’s flu vaccine may not adequately protect recipients from the currently circulating strains of influenza. While we remain in the early stages of the 2014-2015 flu season, over 90 percent of the 1,200 samples submitted to The Centers for Disease Control and Prevention (CDC) have been the H3N2 subtype of influenza A, half of which are genetically drifted strains against which this season’s flu vaccine offers poor protection. […]

Read More…

Don’t Fear Protein Assay Development—Luminex is here!

Are you hiding in the shadows of your laboratory in fear and frustration….wondering how and when you will be saved from the ever-common dilemma of… dun, dun, dun…protein assay development block?!? Never fear… the Luminex Training team can come to the rescue! When you are pondering the question – ‘how do I begin to develop […]

Read More…

The Trouble with Antibiotics

A recent investigation by PBS’ Frontline has shed additional light on the growing threat of antibiotic resistance. A segment titled “The Trouble with Antibiotics” delves into mounting evidence of the global spread of multi-drug resistant bacteria, highlighting the case of Troy Stulen, a 20-year-old who was killed by an antibiotic-resistant bacterial infection following a successful bone marrow transplant at the National Institutes of Health in Bethesda, Maryland. […]

Read More…

November 2014: Recent Papers Using Luminex xMAP Technology

Another month has passed and it’s time to share the highlights of the numerous publications from our customers. We’ve selected six new papers, featuring customer-developed assays and partner kits, which we thought would be especially interesting to you. Our bibliography helps you stay current with the success that your scientific peers are having while using […]

Read More…

Increased Readmission Rates for Survivors of Septic Shock

While advances in the understanding of sepsis have led to improved management and outcomes for patients with septic shock, a recent study published in Critical Care Medicine by researchers at the University of Pennsylvania describe a troubling increase in 30-day hospital readmission rates for survivors of septic shock. […]

Read More…

New Outcomes Data Presented at IDWeek 2014

A study depicting the clinical and economic impact associated with implementing the Verigene® Gram-Positive Blood Culture Test (BC-GP) in combination with antimicrobial stewardship was recently presented by Maggie Box, Pharm.D, of Scripps Health at the 2014 IDWeek meeting. This multi-center, pre-post quasi-experimental analysis was conducted to determine the impact that implementing BC-GP with antimicrobial stewardship had on time to optimal therapy, difference in antimicrobial therapy for blood culture contaminants, hospital length-of-stay, and pharmacy and overall hospital costs. […]

Read More…